These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4665739)

  • 21. Thrombin generation induced by the intrinsic or extrinsic coagulation pathway is accelerated by streptokinase, independently of plasminogen.
    Brommer EJ; Meijer P
    Thromb Haemost; 1993 Dec; 70(6):995-7. PubMed ID: 8165624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on plasminogen activators. I. Sucrose density gradient distribution of activators from normal and lytic human plasma.
    Hamberg U
    Acta Chem Scand; 1966; 20(9):2539-50. PubMed ID: 5965137
    [No Abstract]   [Full Text] [Related]  

  • 23. The sensitivity of rabbit plasminogen to streptokinase in circulating blood.
    Janda R
    Folia Histochem Cytochem (Krakow); 1973; 11(3):235-43. PubMed ID: 4778383
    [No Abstract]   [Full Text] [Related]  

  • 24. The thrombolytic activity of streptokinase in the rabbit.
    English PD; Smith RA; Dupe RJ; Green J; Hibbs MJ
    Thromb Haemost; 1981 Aug; 46(2):535-7. PubMed ID: 7302893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acidosis induced disseminated intravascular microthrombosis and its dissolution by streptokinase.
    Broersma RJ; Bullemer GD; Mammen EF
    Thromb Diath Haemorrh; 1970 Oct; 24(1):55-67. PubMed ID: 5483975
    [No Abstract]   [Full Text] [Related]  

  • 26. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fibrinolysis and thrombolytic therapy under laboratory control].
    Osten W
    Med Lab (Stuttg); 1966 May; 19(5):108-13 contd. PubMed ID: 5982109
    [No Abstract]   [Full Text] [Related]  

  • 28. Preparation of a novel streptokinase mutant with improved stability.
    Shi GY; Chang BI; Su SW; Young KC; Wu DH; Chang LC; Tsai YS; Wu HL
    Thromb Haemost; 1998 May; 79(5):992-7. PubMed ID: 9609235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulation and fibrinolysis are in balance after moderate exercise in middle-aged participants.
    Menzel K; Hilberg T
    Clin Appl Thromb Hemost; 2009; 15(3):348-55. PubMed ID: 19022797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro inhibition of streptokinase-induced proteolysis by Trasylol and by epsilon amino caproic acid (EACA).
    Godal HC; Theodor I
    Scand J Clin Lab Invest; 1965; 17():Suppl 84:199+. PubMed ID: 5295419
    [No Abstract]   [Full Text] [Related]  

  • 31. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
    Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
    Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in human plasma.
    Nielsen VG; Kirklin JK; George JF
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):448-55. PubMed ID: 19581800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [On the demonstration of plasmin deficiency in retracted clots of full blood and on its significance in the lysis with streptokinase].
    Gottlob R; Blümel G
    Thromb Diath Haemorrh; 1966 May; 15(3):570-90. PubMed ID: 5989036
    [No Abstract]   [Full Text] [Related]  

  • 34. Corn trypsin inhibitor decreases tissue-type plasminogen activator-mediated fibrinolysis of human plasma.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):191-6. PubMed ID: 19657316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C; Barton MH; Prasse KW; Moore JN
    J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinase.
    Theiss W; Asbeck F; Kriessmann A; Trübestein G; Knoch K; de Swart CA; Marbert GA; van de Loo JC
    Thromb Haemost; 1983 Oct; 50(3):664-8. PubMed ID: 6196852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro measurement of fibrinolysis by urokinase].
    Senf L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):819-21. PubMed ID: 6176506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasminogen assay by means of the lysis time method.
    Berg W; Korsan-Bengtsen K; Ygge J
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):127-44. PubMed ID: 16955971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative estimation of fibrin stabilizing factor, alterations of its activity by fibrinolysis.
    Heene DL
    Thromb Diath Haemorrh; 1968 Jul; 19(3):600-1. PubMed ID: 5708137
    [No Abstract]   [Full Text] [Related]  

  • 40. Stanozolol-induced changes in fibrinolysis and coagulation in healthy adults.
    Kluft C; Preston FE; Malia RG; Bertina RM; Wijngaards G; Greaves M; Verheijen JH; Dooijewaard G
    Thromb Haemost; 1984 Apr; 51(2):157-64. PubMed ID: 6740547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.